Back to Search Start Over

Study of CRP, ferritin, and D-dimer in COVID-19 RICU patients as per HRCT severity in assiut university hospitals.

Authors :
Abdel-Ghany, Mohamed F.
El-Karn, Atef Farouk Mohamed
Anis, Mina Ibraheem
Youssif, Sahar Farghly
Source :
Egyptian Journal of Bronchology. 10/14/2024, Vol. 18 Issue 1, p1-8. 8p.
Publication Year :
2024

Abstract

Background: Inflammatory markers were found to be elevated in patients with coronavirus disease (COVID-19). C-reactive protein (CRP), serum ferritin, and D-dimer levels may predict morbidity and mortality in (COVID-19) patients. Radiology plays a key role in the diagnosis, management, and follow-up of this disease. This study aimed to describe the radiological features of (COVID-19) infection, measure C-reactive protein (CRP), D-dimer, and ferritin levels and to correlate them with patient's outcome and to consider them as predictors of morbidity and mortality in (COVID-19) patients. Methods: This prospective cross-sectional analytic study had been done on 159 patients aged ≥ 18 years old, admitted at Assiut University Hospital RICU from November 2021 to November 2022, diagnosed as COVID-19 by positive RT-PCR. All patients were categorized on bases of HRCT chest disease reporting and data system (CO-RADS) scoring system into non-severe (CO-RADS 1,2,3) and severe (CO-RADS 4,5) groups. Inflammatory markers such as CRP, ferritin, and D-dimer were measured. Age, sex, comorbidities, need to mechanical ventilation MV, and mortality rate were reported. Correlation between HRCT(CO-RADS) score, inflammatory markers, and patient's outcome was assessed. Results: Higher CRP and serum ferritin levels, lower lymphocytic count, and higher frequency of need for mechanical ventilation were significantly greater in the severe group (P < 0.0001). Predictors of morbidity and mortality were CRP ≥ 133 mg/dl, DM, presence of chronic chest disease (P < 0.0001). A higher mortality rate was in patients of the severe group (65%) versus (9%) in the non-severe group (P < 0.0001). Conclusions: HRCT scan and measurement of CRP and ferritin plasma levels can be considered significant predictors for future prognosis and can early identify patients at risk of death and need for MV. Male gender, presence of DM, and chronic chest diseases are risk factors for severe illness. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16878426
Volume :
18
Issue :
1
Database :
Academic Search Index
Journal :
Egyptian Journal of Bronchology
Publication Type :
Academic Journal
Accession number :
180253946
Full Text :
https://doi.org/10.1186/s43168-024-00340-8